"We are pleased to have been selected by the U.S. Army as their CAD provider and we look forward to partnering with these new users to provide the best breast cancer detection tools available," said Julian Marshall, product management director and principal engineer for computer aided detection at Hologic. The selection of the Hologic R2 CAD technology was made after the Army evaluated the CAD providers. R2 CAD products were selected on the basis of their expandability and flexibility and the Company's long history of innovation.

The R2 ImageChecker was the first CAD system approved by the U.S. Food and Drug Administration (FDA) for use with film-based mammography in 1998 and for digital mammography in 2001. Since 1998, R2 has received multiple supplemental approvals for technological and clinical advances and owns or has exclusive worldwide rights in more than 115 issued and pending patents. To date, more than 3,000 ImageChecker Mammography CAD systems have been sold worldwide. Hologic estimates that over ten million women will have their mammograms interpreted with the aid of R2's leading technology in 2007.

Hologic Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of innovative imaging technology for digital radiography and breast imaging. Hologic's core business units are focused on mammography and breast biopsy, osteoporosis assessment, and mini C-arm and extremity MRI imaging for orthopedic applications. Hologic is the recognized leader in the development and commercialization of computer-aided detection (CAD), an innovative technology that assists physicians in the earlier detection of breast cancer. For more information, visit www.r2tech.com and www.hologic.com.

This release contains forward-looking information that involves risks and uncertainties, including statements regarding Hologic's plans, objectives, expectations and intentions. Such statements include, without limitation, statements regarding purchases of Hologic's products, including any implication of future revenues from existing orders or any implication of future orders. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. In certain circumstances, orders may be canceled or rescheduled by customers without significant penalty. Therefore, orders as of any particular date should not be relied upon as indicative of Hologic's net revenues for any future period. Other factors that could adversely affect the Company's business and prospects are described in the Company's filings with the Securities and Exchange Commission. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based.

ImageChecker is a registered trademark of R2 Technology, Inc